NASDAQ:PRPO Precipio (PRPO) Stock Price, News & Analysis → Elon Musk: THIS will be bigger than Tesla (From Paradigm Press) (Ad) Free PRPO Stock Alerts $5.93 +0.09 (+1.54%) (As of 12:34 PM ET) Add Compare Share Share Today's Range$5.54▼$6.0750-Day Range$5.62▼$6.7452-Week Range$4.75▼$8.99Volume6,088 shsAverage Volume5,575 shsMarket Capitalization$8.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Precipio alerts: Email Address Ad Weiss RatingsMassive Crisis Looming — Protect Your Savings NowToday, Dr. Weiss is coming forward with a new warning, Only this time, it's not about the stock market, inflation, or recession … This time, it's about your financial freedom.Click here to learn how to prepare before it's too late. About Precipio Stock (NASDAQ:PRPO)Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.Read More PRPO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRPO Stock News HeadlinesJune 13, 2024 | globenewswire.comPrecipio Inc. Announces Adjournment of Annual Meeting of StockholdersJune 12, 2024 | globenewswire.comPrecipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders MeetingMay 15, 2024 | msn.comPRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024May 6, 2024 | globenewswire.comPrecipio Secures a short-term $500K Credit FacilityApril 20, 2024 | finance.yahoo.comPrecipio, Inc. (PRPO) Latest Stock News & Headlines - Yahoo FinanceApril 19, 2024 | morningstar.comPrecipio Inc PRPOMarch 25, 2024 | globenewswire.comPrecipio Announces Year end 2023 Shareholder Update CallMarch 12, 2024 | ca.finance.yahoo.comPrecipio, Inc. (PRPO)February 23, 2024 | benzinga.comPrecipio Stock (NASDAQ:PRPO), Analyst Ratings, Price Targets, PredictionsFebruary 13, 2024 | finance.yahoo.comPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoYFebruary 6, 2024 | finanznachrichten.dePrecipio, Inc.: Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for CancerJanuary 23, 2024 | msn.comPrecipio’s Q4 cash burn from operations drops below $100K for full quarterJanuary 23, 2024 | finanznachrichten.dePrecipio, Inc.: Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterJanuary 23, 2024 | finance.yahoo.comPrecipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterJanuary 17, 2024 | finanznachrichten.dePrecipio, Inc.: Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in JapanJanuary 17, 2024 | finance.yahoo.comPrecipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in JapanJanuary 2, 2024 | finance.yahoo.comPrecipio Announces Christina Valauri joins the Board of DirectorsDecember 15, 2023 | finanznachrichten.dePrecipio, Inc.: Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024December 14, 2023 | finance.yahoo.comPrecipio Management Shares Thoughts on 2023, and Looks Ahead To 2024October 18, 2023 | finance.yahoo.comPrecipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022October 3, 2023 | finanznachrichten.dePrecipio, Inc.: Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023October 3, 2023 | finance.yahoo.comPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023September 28, 2023 | finance.yahoo.comPrecipio Continues to Sign New HemeScreen™ CustomersSeptember 25, 2023 | finance.yahoo.comPrecipio Reduces Product Revenue Result Needed for Cash Flow BreakevenSeptember 22, 2023 | finanznachrichten.dePrecipio, Inc.: Precipio Takes Final Step Towards Regaining Nasdaq ComplianceSee More Headlines Receive PRPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today6/17/2024Next Earnings (Estimated)8/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolNASDAQ:PRPO CUSIPN/A CIK1043961 Webwww.precipiodx.com Phone(203) 787-7888Fax402-452-5401Employees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,850,000.00 Net Margins-31.00% Pretax Margin-31.00% Return on Equity-46.12% Return on Assets-34.19% Debt Debt-to-Equity Ratio0.01 Current Ratio0.78 Quick Ratio0.62 Sales & Book Value Annual Sales$15.20 million Price / Sales0.56 Cash FlowN/A Price / Cash FlowN/A Book Value$10.16 per share Price / Book0.57Miscellaneous Outstanding Shares1,470,000Free Float1,313,000Market Cap$8.58 million OptionableNo Data Beta1.27 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Ilan Danieli (Age 52)Founder, President, CEO & Director Comp: $325.06kMr. Ahmed Zaki Sabet (Age 38)Chief Operating Officer Comp: $220.82kDr. Ayman A. Mohamed M.D. (Age 39)Chief Technology Officer Comp: $225.15kMr. Matthew Gage (Age 57)Chief Financial Officer Ms. Miri Chiko-RadomskiChief Legal Counsel & People OfficerKey CompetitorsRapid Micro BiosystemsNASDAQ:RPIDAccelerate DiagnosticsNASDAQ:AXDXSingular Genomics SystemsNASDAQ:OMICTalis BiomedicalNASDAQ:TLISAstrotechNASDAQ:ASTCView All Competitors PRPO Stock Analysis - Frequently Asked Questions How have PRPO shares performed in 2024? Precipio's stock was trading at $6.50 at the beginning of the year. Since then, PRPO shares have decreased by 8.8% and is now trading at $5.93. View the best growth stocks for 2024 here. When is Precipio's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, August 9th 2024. View our PRPO earnings forecast. How were Precipio's earnings last quarter? Precipio, Inc. (NASDAQ:PRPO) issued its quarterly earnings results on Tuesday, May, 14th. The biotechnology company reported ($1.46) EPS for the quarter. The biotechnology company had revenue of $3.43 million for the quarter. Precipio had a negative net margin of 31.00% and a negative trailing twelve-month return on equity of 46.12%. When did Precipio's stock split? Shares of Precipio reverse split on the morning of Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Precipio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Jaguar Health (JAGX). How do I buy shares of Precipio? Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRPO) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored"Trump Loophole" Beats InflationThe demise of the "petrodollar" appears imminent. And the implications for Americans could be dire.Colonial Metals | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.